Skip to main content

Category: Injection Treatments

Request A Consultation

August 15, 2011 | Injection Treatments

How Often to Get Botox May Be Less than Thought

After a period of two years undergoing Botox treatments, patients may reduce the frequency of treatments to every six months and achieve the same benefits, according to a study by the Oregon Health & Science University’s Casey Eye Institute that looked at how often to get Botox. When looking at a group of 50 women, […]

Read More

May 16, 2011 | Injection Treatments

Injectable Fillers: The Key to Improving Your Sex Life?

young woman with short hair looking at an orange slice in her hand

Since the introduction of Restylane, the first FDA-approved hyaluronic acid (HA) injectable filler, into the U.S. cosmetic medical market in 2004, physicians and scientists have discovered a multitude of uses for HA fillers far beyond their original indication for correction of facial wrinkles and folds. Today, products from the Restylane and Juvederm families of HA fillers are […]

Read More

April 04, 2011 | Injection Treatments

Botox Alternative to Freeze Facial Wrinkles

black and white portrait of a youn woman's face with hands on her face

Botox and Dysport may soon have competition in your surgeon’s office if early trials of a wrinkle freezing treatment see continued success, according to U.S. News. Though both Botox and Dysport are hugely popular non-surgical options for diminishing many facial lines and wrinkles, new alternatives are often being researched. This treatment, which is called cryoneuromodulation, […]

Read More

March 07, 2011 | Injection Treatments

Prospect of Topical Botox Grows

handsome man smiling 

It’s certainly not news that wrinkle-reducing injectables like Botox and Dysport are seeing sales increases as the economy rebounds. It is noteworthy, however, what the companies are working toward in the wake of renewed consumer interest—topical versions, according to bnet.com. Botox, produced by Allergan and Dysport, produced by Medicis, contain similar components of the botulinum […]

Read More

December 21, 2010 | Injection Treatments

Merz’s New Injectable Belotero Outlasts Collagen, Study Finds

front view of a young woman's face with a syringe near her lips

According to the results of a 24-week study published in Dermatologic Surgery, Belotero, the new hyaluronic acid filler by Merz, provides longer-lasting wrinkle correction than bovine collagen injectables. The study results come at a time when Belotero is awaiting FDA approval and pharmaceutical competitor Allergan is pulling its bovine collagen injectables Zyderm and Zyplast, as […]

Read More

November 04, 2010 | Injection Treatments

Want To Make A Good First Impression? Try Injectable Fillers

When most people meet for the first time, they consciously or subconsciously make quick judgments based on a person’s physical appearance to determine their first impression. Eugene plastic surgeon Dr. Lee Daniel is acutely aware of this human tendency and often meets patients who seek cosmetic treatment to not only feel better about themselves, but […]

Read More

September 06, 2010 | Injection Treatments

More Than 100,000 Patients Take the Dysport Challenge

Medicis, pharmaceutical giant and makers of the popular wrinkle filler Restylane, launched a rebate promotion in March 2010 to promote its injectable wrinkle relaxer and Botox competitor Dysport.  To date, more than 100,000 patients have taken the so-called “Dysport Challenge.” The Dysport Challenge promotion essentially rewards patients who report whether they were satisfied with their Dysport […]

Read More

August 06, 2010 | Injection Treatments

Xeomin Injectable Wrinkle Relaxer Reaches U.S.

xeomin logo

Xeomin, a botulinum type A injectable treatment made by German pharmaceutical giant Merz, was finally FDA-approved to join Botox and Dysport on the U.S. market in late September, after having been available in Europe since 2008. Xeomin will likely compete with Botox and Dysport for a share of patients seeking to reduce forehead creases and […]

Read More

Contact Us

We Would Love To Hear From You